|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| Choose application no.
|
|
| |
|
|
| Application no. and date | 21713415.4 (espacenet) (Federated) (European Patent Register), 20210324 | | Patent/reg. no. and date | DK/EP 4126237, 20240410 | | Publication date | 20230208 | | Priority no. and date | EP 20165898, 20200326 | | EP pub. no. and date |
EP 4126237 20230208 | | Effective date | | | Applicant/owner | LEK Pharmaceuticals d.d., Verovskova 57
1526 Ljubljana, SI | | Applicant ref. no. | | | Inventor | PEKLAR, Boris, c/o LEK Pharmaceuticals d.d. Verovska 57
1526 Ljubljana, SI | | Representative | | | Opponent | | | IPC Class | A61K 31/4178 (2006.01) , A61P 35/00 (2006.01) , C07D 401/04 (2006.01) | | Title | DIMALEATE FORM OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYANOPHENYL)UREA | | Int. application no. | EP2021057575 | | Int. publication no. | WO2021191278 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
